Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema

K. Malakauskas, R. Sakalauskas, V. Dudzevicius, R. Planciuniene (Kaunas, Lithuania)

Source: Annual Congress 2001 - Mechanisms of airway inflammation in asthma and COPD
Session: Mechanisms of airway inflammation in asthma and COPD
Session type: Thematic Poster Session
Number: 1698
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Malakauskas, R. Sakalauskas, V. Dudzevicius, R. Planciuniene (Kaunas, Lithuania). Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema. Eur Respir J 2001; 16: Suppl. 31, 1698

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005

Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Increased levels of hyaluronan in induced sputum from COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD
Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Year: 2009


Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Leptin levels are associated with reduced lung function in men with COPD
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Elevation of serum tumor markers in patients with interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010


Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002

Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012


Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003